Listing 1 - 10 of 29 | << page >> |
Sort by
|
Choose an application
Nuclear energy --- Nuclear engineering --- Nuclear Energy. --- Engineering. --- Nuclear Physics. --- Radiation. --- Patents as Topic. --- Nuclear energy. --- Patents --- Nuclear Energy --- Engineering --- Nuclear Physics --- Radiation --- Patents as Topic
Choose an application
Competition, Unfair. --- Concurrence déloyale. --- Marketing. --- Marques de commerce. --- Patents as Topic. --- Trademarks. --- marketing. --- trademarks.
Choose an application
Antineoplastic agents --- Patents --- Antineoplastic Agents. --- Neoplasms --- Patents as Topic. --- drug therapy.
Choose an application
Drug Approval --- Pharmaceutical Preparations --- Drugs --- Patents --- Drug Approval. --- Patents as Topic. --- Pharmaceutical Preparations. --- Therapeutics.
Choose an application
Cardiovascular agents --- Cardiovascular system --- Patents --- Cardiovascular Agents. --- Cardiovascular Diseases --- Patents as Topic. --- Diseases --- drug therapy.
Choose an application
Nuclear energy --- Nuclear engineering --- Nuclear Energy --- Engineering --- Nuclear Physics --- Radiation --- Patents as Topic --- Nuclear energy --- Patents
Choose an application
"This timely volume offers expert analyses of the challenges facing crucial aspects of trademark law from some of the most prominent scholars in the field."--Back cover.
Choose an application
Copyright --- Information superhighway --- Information technology --- Intellectual property --- Information Services --- Computer Communication Networks --- Patents as Topic --- legislation & jurisprudence. --- trends. --- United States.
Choose an application
Concerns have been expressed that gene patents might result in restricted access to research and health care. The exponential growth of patents claiming human DNA sequences might result in patent thickets, royalty stacking and, ultimately, a 'tragedy of the anti-commons' in genetics. The essays in this 2009 book explore models designed to render patented genetic inventions accessible for further use in research, diagnosis or treatment. The models include patent pools, clearing house mechanisms, open source structures and liability regimes. They are analysed by scholars and practitioners in genetics, law, economics and philosophy. The volume looks beyond theoretical and scholarly analysis by conducting empirical investigation of existing examples of collaborative licensing models. Those models are examined from a theoretical perspective and tested in a set of operational cases. This combined approach is unique in its kind and prompts well founded and realistic solutions to problems in the current gene patent landscape.
Genetics --- Licensure --- Models, Economic. --- Patents as Topic --- ethics. --- legislation & jurisprudence. --- Biology --- Embryology --- Mendel's law --- Adaptation (Biology) --- Breeding --- Chromosomes --- Heredity --- Mutation (Biology) --- Variation (Biology)
Choose an application
Drug Industry --- Drugs, Essential. --- Drugs. --- Health services accessibility. --- Intellectual Property. --- Intellectual property. --- Medical policy. --- Patent laws and legislation. --- Patents --- Pharmaceutical industry. --- World health. --- Ethics. --- Intellecutal Property --- Global Health --- Patents as Topic --- ethics. --- ethics --- Drug Industry - ethics. --- Patents as Topic - ethics --- Droit médical
Listing 1 - 10 of 29 | << page >> |
Sort by
|